Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
CHRNB1 Biologics Sequence Review Report 2026: Acetylcholine receptor subunit beta Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CHRNB1 Biologics Sequence Review Report 2026: Acetylcholine receptor subunit beta Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CHRNG Biologics Sequence Review Report 2026: Acetylcholine receptor subunit gamma Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CHRNG Biologics Sequence Review Report 2026: Acetylcholine receptor subunit gamma Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNG protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CHRNB2 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit beta-2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CHRNB2 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit beta-2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNB2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CASR Biologics Sequence Review Report 2026: Extracellular calcium-sensing receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CASR Biologics Sequence Review Report 2026: Extracellular calcium-sensing receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CASR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CHRNA4 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-4 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CHRNA4 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CHRNA7 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-7 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CHRNA7 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-7 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CHRNA5 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CHRNA5 Biologics Sequence Review Report 2026: Neuronal acetylcholine receptor subunit alpha-5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CHRNA5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
IGF1R Biologics Sequence Review Report 2026: Insulin-like growth factor 1 receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
IGF1R Biologics Sequence Review Report 2026: Insulin-like growth factor 1 receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of IGF1R protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
MET Biologics Sequence Review Report 2026: Hepatocyte growth factor receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
MET Biologics Sequence Review Report 2026: Hepatocyte growth factor receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of MET protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ADGRL2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ADGRL2 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ADGRL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
ADGRL1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
ADGRL1 Biologics Sequence Review Report 2026: Adhesion G protein-coupled receptor L1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of ADGRL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
NGF Biologics Sequence Review Report 2026: Beta-nerve growth factor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
NGF Biologics Sequence Review Report 2026: Beta-nerve growth factor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of NGF protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →